Fast Five Quiz: Test Your Knowledge of Systemic Treatment for Metastatic Breast Cancer

Winston W. Tan, MD


June 01, 2020

Breast cancer remains the most common type of cancer in women, with approximately 2.1 million affected each year worldwide, and the leading cause of cancer-related deaths among women. An estimated 627,000 women died from breast cancer in 2018, representing approximately 15% of all cancer deaths among women. Although the highest rates of breast cancer are seen among women in more developed areas, the incidence of breast cancer is increasing in nearly every region globally, and 5%-10% of breast cancer patients have metastatic disease at presentation. Although treatments for metastatic breast cancer continue to improve, it remains virtually incurable.

In general, recurrent or metastatic breast cancer must be approached systemically so that the therapeutic effect reaches all sites of disease. This may include hormone therapy, chemotherapy, targeted therapy, immunotherapy, or a combination of these.

How much do you know about systemic treatment for metastatic breast cancer? Test your knowledge with this short quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.